证券代码：000920 证券简称：沃顿科技 公告编号：2024-017 沃顿科技股份有限公司 关于参加 2023 年度贵州辖区上市公司业绩说明会暨投资者 集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 沃顿科技股份有限公司（以下简称"公司"）已分别披露 2023 年 度报告和 2024 年一季度报告，为便于广大投资者更深入全面地了解 公司情况，公司将参加由贵州证监局指导、贵州证券业协会与深圳市 全景网络有限公司联合举办的"2023 年度贵州辖区上市公司业绩说明 会暨投资者集体接待日活动"。本次活动具体安排如下： 召开方式：网络远程方式。 一、业绩说明会的安排 召开时间：2024 年 5 月 9 日（星期四）15:40 至 17:30。 出席人员：公司董事长蔡志奇先生、独立董事徐翔先生、董事会 秘书赵峰先生。 参与方式：投资者可登录 http://rs.p5w.net 进入专区页面参与交流。 二、投资者问题征集及方式 为广泛听取投资者的意见和建议、提升交流效率及针对性，本次 业绩说明会公司将提前向广大投资者开展问题征集，提问通道自本公 告发 ...

国浩律师（贵阳）事务所 法律意见书 国浩律师（贵阳）事务所 关于沃顿科技股份有限公司2023年度股东大会 的法律意见书 国浩所（2024）法意字第 0185 号 国浩律师（贵阳）事务所（以下简称"本所"）接受沃顿科技 股份有限公司（以下简称"沃顿科技"）的委托，指派宋诗阳、杨 波律师出席沃顿科技 2023 年度股东大会（简称"本次股东大会"）， 就本次股东大会有关法律事宜进行现场查验，并出具本法律意见 书。 本所律师根据《中华人民共和国公司法》《中华人民共和国证 券法》《上市公司股东大会规则》等法律、法规和规范性文件以及 《沃顿科技股份有限公司章程》（简称"《公司章程》"），对本次股 东大会的召集、召开程序，出席会议人员、召集人的资格，会议 的表决程序及表决结果等有关法律事宜进行了查验，现出具法律 意见如下: 一、本次股东大会的召集与召开程序 沃顿科技董事会已于 2024 年 3 月 29 日在《证券时报》和"巨 潮资讯网"上刊登了《沃顿科技股份有限公司关于召开公司 2023 年度股东大会的通知》，在法定期限内公告了有关本次股东大会的 召开时间、地点、方式、审议事项、出席会议人员的资格、会议 登记办法等相关事 ...

证券代码：000920 证券简称：沃顿科技 公告编号：2024-015 沃顿科技股份有限公司 2023 年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： （一）本次股东大会未出现否决提案的情形。 （二）本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开的情况 1、现场会议召开时间：2024 年 4 月 23 日 15:00。 2、网络投票时间： （1）通过交易系统进行网络投票的时间为 2024 年 4 月 23 日 9:15 至 9:25，9:30 至 11:30 和 13:00 至 15:00； （2）通过互联网投票系统进行网络投票的时间为 2024 年 4 月 23 日 9:15 至 15:00。 （二）召开地点：贵州省贵阳市贵阳国家高新技术产业开发区黎 阳大道 1518 号 102 五楼会议室 （三）召开方式：现场表决与网络投票相结合 （四）召集人：公司董事会 （五）主持人：董事长蔡志奇先生 （一）召开时间 （六）公司董事、监事、高级管理人员、国浩律师（贵阳）事务 所见证律师出席了会议。 （七）会议的召集、召开 ...

Financial Performance - The company's revenue for Q1 2024 was ¥335,125,944.26, representing a 2.82% increase compared to ¥325,935,494.50 in the same period last year[5] - Net profit attributable to shareholders was ¥34,098,070.09, a 19.65% increase from ¥28,499,083.40 year-over-year[5] - Basic earnings per share rose to ¥0.0721, reflecting a 19.57% increase from ¥0.0603 in the same quarter last year[5] - Net profit for Q1 2024 reached CNY 35,663,332.22, compared to CNY 28,865,557.60 in Q1 2023, representing a year-over-year increase of 23.8%[19] - Other comprehensive income after tax for Q1 2024 was CNY 4,855,321.88, compared to a loss of CNY 42,895,960.55 in the same period last year[19] - The company reported a comprehensive income total of CNY 40,518,654.10 for Q1 2024, contrasting with a loss of CNY 14,030,402.95 in Q1 2023[20] Cash Flow - The net cash flow from operating activities surged to ¥69,076,078.69, marking a significant increase of 512.27% compared to ¥11,282,006.44 in the previous year[5] - Total cash inflow from operating activities reached ¥305,295,286.58, compared to ¥279,948,939.54 in the prior period, indicating a growth of approximately 9%[21] - Cash outflow from operating activities decreased to ¥236,219,207.89 from ¥268,666,933.10, resulting in improved cash flow management[21] - The net cash flow from financing activities increased dramatically to ¥36,000,000.00, a 2999.62% rise from -¥1,241,541.66 in the same period last year[9] - The net increase in cash and cash equivalents for the period was ¥99,560,059.51, a recovery from a decrease of -¥5,293,377.85 in the prior period[22] - The company received ¥6,507,848.35 in tax refunds, up from ¥3,086,576.46, contributing positively to cash flow[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,553,501,346.36, up 3.47% from ¥2,467,945,325.52 at the end of the previous year[5] - Total liabilities for Q1 2024 were CNY 553,129,970.52, slightly up from CNY 544,618,476.13 in the previous year, reflecting an increase of 1.0%[17] - The total equity attributable to shareholders of the parent company was CNY 1,836,010,932.82, compared to CNY 1,796,603,051.63 in Q1 2023, showing an increase of 2.2%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 27,000[10] - The largest shareholder, CRRC Industry Investment Co., Ltd., holds 43.95% of shares, totaling 207,733,059 shares[10] - The number of shares held by the top ten unrestricted shareholders includes 182,422,500 shares held by CRRC Industry Investment Co., Ltd.[10] Operational Highlights - The company reported a 51.73% increase in contract liabilities, reaching ¥94,071,291.41, compared to ¥61,998,046.45 at the beginning of the year[9] - The company experienced an 81.22% increase in investment income, amounting to ¥36,979.57, compared to ¥20,406.36 in the previous year[9] - The company reported a significant increase in other operating income, which rose to ¥217,051.19, a 1708.74% increase from ¥12,000.16 in the previous year[9] - R&D expenses increased to CNY 22,622,481.07 in Q1 2024, up from CNY 19,626,790.77 in Q1 2023, marking a rise of 15.3%[19] Inventory and Receivables - Accounts receivable rose to ¥211,711,668.58 from ¥188,897,534.98, indicating an increase of about 12.1%[15] - Inventory decreased slightly to ¥195,049,387.13 from ¥196,261,865.35, a decline of approximately 0.6%[15] - The company reported a decrease in other receivables from ¥18,868,893.62 to ¥8,813,842.90, a decline of approximately 53.3%[15] Strategic Initiatives - The company plans to increase its shareholding by purchasing between ¥50 million and ¥100 million worth of shares, not exceeding 2% of the total share capital[13] - The company signed a procurement contract for reverse osmosis membrane materials with Longyuan Environmental Protection Nanjing Co., Ltd. for the years 2023-2024[12] - The company entered into a financial services framework agreement with CRRC Finance Co., Ltd. to provide various financial services[12] Audit Status - The company has not yet audited the first quarter report, which may impact the reliability of the financial data presented[23]

证券代码：000920 证券简称：沃顿科技 公告编号：2024-014 沃顿科技股份有限公司 关于控股股东增持股份比例达到 1%暨增持计划进展的公告 近日，沃顿科技股份有限公司（以下简称"公司"）收到控股股 东中车产业投资有限公司（以下简称"中车产投"）出具的《中车产 业投资有限公司关于增持沃顿科技股份有限公司股票进展的通知》， 中车产投于 2024 年 3 月 1 日至 2024 年 4 月 16 日通过深圳证券交易 所交易系统的集中竞价交易累计增持公司股份 7,212,200 股，占公司 总股本的 1.53%。中车产投增持计划详见公司刊载于《证券时报》及 "巨潮资讯网"的《关于控股股东增持公司股份暨后续增持计划的公 告》（公告编号：2024-003），现将有关情况公告如下： | 信息披露义务人 | | 中车产业投资有限公司 | | | --- | --- | --- | --- | | 住所 | | 北京市丰台区汽车博物馆西路 | 8 号院 1 号楼 11 层 1101 | | 权益变动时间 | | 2024 年 3 月 1 日至 2024 年 | 4 月 16 日 | | 股票简 称 | | 沃顿科技 ...

（二）召集人：公司董事会。 证券代码：000920 证券简称：沃顿科技 公告编号：2024-013 沃顿科技股份有限公司 关于召开公司 2023 年度股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 沃顿科技股份有限公司（以下简称"公司"）将于 2024 年 4 月 23 日召 开公司 2023 年度股东大会，具体内容详见刊载于"巨潮资讯网"（网址： www.cninfo.com.cn）和《证券时报》的《关于召开公司 2023 年度股东大会 的通知》（公告编号：2024-011），现就此次股东大会的有关事项提示公告如 下： 一、召开会议基本情况 （一）股东大会届次：2023 年度股东大会。 （三）本次股东大会会议召开符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 （四）召开方式：本次股东大会采取现场投票、网络投票相结合的方 式。公司将通过深圳证券交易所交易系统和互联网投票系统向公司股东提 供网络形式的投票平台，公司股东可以在下述网络投票时间内通过深圳证 券交易所的交易系统或互联网投票系统行使表决权。 （五）召开时间 1 ...

国海证券股份有限公司 关于沃顿科技股份有限公司 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导性陈述或 重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法律责任。 2、保荐机构及保荐代表人自愿接受中国证监会对保荐总结报告书相关事项进行的任 何质询和调查。 3、保荐机构及保荐代表人自愿接受中国证监会按照《证券发行上市保荐业务管理办 法》的有关规定采取的监管措施。 二、保荐机构基本情况 非公开发行股票持续督导保荐总结报告书 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准沃顿科技股份有限 公司非公开发行股票的批复》（证监发行字[2022]2754 号）核准，沃顿科技股份有限公司 （以下简称"沃顿科技"、"公司"或"发行人"）以非公开发行股票的方式向中车产业投资有 限公司（以下简称"中车产投"）、国能龙源环保有限公司（以下简称"龙源环保"）非公开 发行不超过 50,621,118 股股票，本次实际募集资金为 407,499,999.90 元，发行数量为 50,621,118 股。国海证券股份有限公司（以下简称"国海证券"、"保荐机构"）为沃顿 ...

证券代码：000920 证券简称：沃顿科技 公告编号：2024-012 沃顿科技股份有限公司 沃顿科技股份有限公司（以下简称"公司"）2024 年 1 月至 2024 年 3 月新签订的膜分离工程业务合同金额为人民币 26,613.29 万元。 具体情况如下： | 序号 | 应用领域 | 合同金额（万元） | | --- | --- | --- | | 1 | 膜法浓缩分离——盐湖提锂 | 22,494.97 | | 2 | 膜法工业废水处理及资源化利用——磷酸铁 | 3,753.20 | | 3 | 膜法工业废水处理——煤矿及化工 | 365.12 | | | 合计 | 26,613.29 | 截至本公告披露日，公司尚未执行完毕的在手合同金额合计约 5.375 亿元。上述在手订单数据源自合同金额统计，各项目交付周期 差异较大，不能以此直接推算公司本年度营业收入、净利润等财务数 据。在手合同可能根据客户需求或项目实际发生一定变动，也可能因 统计口径差异、税收等各种因素导致财务核算存在一定差异。以上数 据仅供投资者及时了解公司膜分离工程业务日常经营概况，公司财务 数据以公司披露的定期报告为准。敬请广大投资者理性 ...

Financial Performance - The company's operating revenue for 2023 was ¥1,705,162,988.10, representing a 16.68% increase compared to ¥1,461,340,100.57 in 2022[6]. - The net profit attributable to shareholders for 2023 was ¥164,744,450.47, up 13.64% from ¥144,973,542.69 in 2022[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥156,508,786.41, reflecting a 20.02% increase from ¥130,404,049.12 in 2022[6]. - The total assets at the end of 2023 were ¥2,467,945,325.52, a decrease of 15.53% from ¥2,921,706,666.58 at the end of 2022[6]. - The net assets attributable to shareholders increased by 2.14% to ¥1,796,603,051.63 at the end of 2023 from ¥1,758,954,443.56 at the end of 2022[6]. - The company reported a basic earnings per share of ¥0.35 for 2023, a 2.94% increase from ¥0.34 in 2022[6]. - The company achieved a total revenue of CNY 1,705,162,988.10 in 2023, representing a year-on-year growth of 16.68%[63]. - The net profit attributable to shareholders was CNY 16,474,450,000, an increase of 13.64% compared to the previous year[58]. - The total revenue from membrane products reached ¥969,830,816.90 with sales of 6,308,892 units, maintaining stable pricing trends[67]. - The company reported a significant increase in revenue, reaching 1.5 billion yuan, representing a 20% year-over-year growth[145]. Dividend Distribution - The company plans to distribute a cash dividend of 1.23 RMB per 10 shares to all shareholders, based on a total of 472,621,118 shares[5]. - The company implemented a cash dividend policy, distributing 1.23 CNY per 10 shares, totaling 58,132,397.51 CNY, which represents 100% of the total profit distribution[168][172]. Business Transformation and Strategy - The company has undergone a significant business transformation since 2014, shifting its main operations from railway freight cars to composite reverse osmosis membrane business and related sectors[21]. - The company aims to expand its market presence by exploring new markets and enhancing the efficiency of product integration and development[45]. - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development[140]. - The company plans to strengthen overseas market channels and improve risk prevention capabilities in response to geopolitical and trade policy uncertainties[117]. - The company intends to expand its product matrix through mergers and acquisitions, achieving diversified technological development[115]. Research and Development - The company has a mature R&D system, focusing on strategic and demand-driven research to enhance core competitiveness and ensure sustainable development[44]. - The company is investing 100 million yuan in R&D for new technologies aimed at enhancing product efficiency[145]. - R&D investment increased by 29.86% to ¥121,311,861.24 in 2023, accounting for 7.11% of operating revenue[81]. - The company has accumulated 157 valid patents, including 73 invention patents, 65 utility model patents, and 19 design patents as of the end of the reporting period[51]. Market Position and Product Development - The company continues to strengthen its position in the membrane separation technology market, which is increasingly recognized for its efficiency and environmental benefits[34]. - The company has developed over 200 specifications across more than 20 series of membrane products, catering to various applications such as household, commercial, and industrial uses[39]. - The company’s membranes are utilized in various industries, including food and beverage, medical pharmaceuticals, municipal water treatment, and wastewater recycling[39]. - The company launched new products including TAPU-LS, TAPU-MS, TAPU-HS municipal nanofiltration membranes, and Helixfil series anti-pollution membranes, which received positive feedback[59]. Corporate Governance - The company is committed to enhancing its corporate governance structure in accordance with legal and regulatory requirements[129]. - The company has maintained transparency in its operations and financial reporting through regular updates to investors[126]. - The company emphasizes the importance of independent directors in protecting the rights of all shareholders[129]. - The company has established a robust corporate governance system to improve governance levels continuously[129]. Environmental Responsibility - The company has a commitment to environmental responsibility, as indicated in its annual report[5]. - The company has achieved environmental and occupational health safety management system certification, demonstrating commitment to safety standards[187]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[185]. Operational Efficiency - The company operates on a "sales-driven production" model, dynamically adjusting production plans based on sales feedback and operational capacity[43]. - The company is focused on monitoring raw material prices and establishing long-term supplier relationships to mitigate procurement risks[119]. - The company plans to implement cost-cutting measures, aiming for a 10% reduction in operational expenses[145]. Employee Management - The total number of employees at the end of the reporting period was 1,359, with 772 in production, 105 in sales, and 322 in technical roles[164]. - The company plans to continue enhancing employee training across various functions to improve business capabilities[166]. - The company has no retired employees requiring pension costs, indicating a focus on current workforce management[164]. Community Engagement - The company donated teaching facilities worth CNY 600,000 to a local kindergarten to support education initiatives[189]. - The company has developed a rural revitalization work plan for 2023, including regular evaluations and support for local projects[188].

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Views - The company's membrane separation business is entering a rapid development phase, with a projected net profit of 209 million yuan for 2024, 246 million yuan for 2025, and 285 million yuan for 2026, corresponding to PE ratios of 19, 16, and 14 times respectively [2][3] - The company achieved a revenue of 1.705 billion yuan in 2023, representing a year-on-year growth of 16.68%, and a net profit of 165 million yuan, with a year-on-year increase of 13.64% [17] Financial Summary - Total revenue (million yuan): - 2022: 1,461 - 2023: 1,705 - 2024E: 2,091 - 2025E: 2,537 - 2026E: 3,049 - Year-on-year growth rates (%): - 2022: 5.8 - 2023: 16.7 - 2024E: 22.6 - 2025E: 21.3 - 2026E: 20.2 - Net profit (million yuan): - 2022: 145 - 2023: 165 - 2024E: 209 - 2025E: 246 - 2026E: 285 - Year-on-year growth rates (%): - 2022: 19.4 - 2023: 13.6 - 2024E: 27.0 - 2025E: 17.6 - 2026E: 15.8 - Earnings per share (yuan/share): - 2022: 0.31 - 2023: 0.35 - 2024E: 0.44 - 2025E: 0.52 - 2026E: 0.60 - Gross margin (%): - 2022: 35.7 - 2023: 35.9 - 2024E: 36.1 - 2025E: 36.0 - 2026E: 35.8 - Return on equity (ROE %): - 2022: 8.2 - 2023: 9.2 - 2024E: 10.4 - 2025E: 10.9 - 2026E: 11.2 [3][18] Business Development - The company is increasing investment in membrane separation projects, achieving large orders worth over 100 million yuan and making breakthroughs in overseas markets [1] - The membrane products revenue is steadily growing, with the company exploring potential in various sectors such as industrial water, seawater desalination, and municipal water supply [12][22] - The company is enhancing its product structure and market coverage through the gradual ramp-up of its Shawan Phase III project, which will add significant production capacity [22]